SCHEMBL751561

SCHEMBL751561

CC(C)(C)c1ccc(S(=O)(=O)C(I)I)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
LMNA P02545 3/20 0.44
HSD11B1 P28845 3/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 3/20 0.43
HPGD P15428 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C19 P33261 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 2/20 0.43
NPC1 O15118 1/20 0.43
GMNN O75496 1/20 0.43
DRD1 P21728 1/20 0.43
DRD3 P35462 1/20 0.43
CCR2 P41597 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9906396 0.81 ALDH1A1 (0.57) ALDH1A1LMNAHSD11B1GAAMAPT
SCHEMBL30227125 0.79 ALDH1A1 (0.55) ALDH1A1LMNAHSD11B1GAAMAPT
SCHEMBL8745537 0.78 ALDH1A1 (0.53) ALDH1A1LMNAHSD11B1GAAMAPT
SCHEMBL10179517 0.76 ALDH1A1 (0.52) ALDH1A1LMNAHSD11B1GAAMAPT
SCHEMBL27694463 0.76 GAA (0.54) ALDH1A1GAAMAPTHPGDKMT2A
SCHEMBL21818 0.76 GAA (0.54) ALDH1A1GAAMAPTHPGDKMT2A
SCHEMBL548599 0.75 ALDH1A1 (0.67) ALDH1A1LMNAHSD11B1GAAMAPT
SCHEMBL9360098 0.75 ALDH1A1 (0.67) ALDH1A1LMNAHSD11B1GAAMAPT
SCHEMBL11326333 0.75 ALDH1A1 (0.50) ALDH1A1LMNAHSD11B1GAAMAPT
SCHEMBL752415 0.75 ESR1 (0.44) ALDH1A1HSD11B1SMN1; SMN2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-4026918-A D-homosteroids FURST ANDOR 1977-05-31 US disclosed
US-4018611-A Non-yellowing antimicrobial compositions comprising diiodomethyl sulfones METALORGANA ETABLISSEMENT (FL) 1977-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M ALDH1A1 553/4885LMNA 2449/4885HSD11B1 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.